Welcome to our dedicated page for OMEGA HEALTHCARE INVESTORS SEC filings (Ticker: OHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OMEGA HEALTHCARE INVESTORS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OMEGA HEALTHCARE INVESTORS's regulatory disclosures and financial reporting.
Omega Healthcare Investors, Inc. (NYSE: OHI) has filed an 8-K disclosing the completion of a $600 million underwritten public offering of 5.200% Senior Notes due July 1, 2030. The Notes were priced at 99.118% of par, generating gross proceeds of approximately $594.7 million before expenses. They are unsecured, rank pari passu with the company’s other senior debt, and are guaranteed by OHI Healthcare Properties Limited Partnership along with any future subsidiaries that guarantee at least $100 million of Omega’s unsecured borrowings.
Interest accrues semi-annually beginning January 1, 2026. Omega may redeem the Notes at a make-whole premium before June 1, 2030 (the “Par Call Date”) or at par thereafter. Covenants restrict additional indebtedness, asset sales, and require maintenance of an unencumbered asset pool; customary events of default include cross-acceleration and insolvency. Net proceeds are earmarked for general corporate purposes, potentially including repayment of existing debt and future healthcare real-estate investments.
This issuance extends Omega’s debt maturity profile to 2030, adds liquidity for potential acquisitions, and modestly increases fixed-rate leverage at a coupon reflective of current REIT bond markets.